{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:03Z","timestamp":1791582483887,"version":"4.3.4"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T00:00:00Z","timestamp":1364342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058504","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T21:15:38Z","timestamp":1364418938000},"page":"e58504","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma"],"prefix":"10.1371","volume":"8","author":[{"given":"Mary M.","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Bemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Belch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Pilarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Shively","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kirshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10522-010-9287-2","article-title":"Aging, frailty and age-related diseases","volume":"11","author":"T Fulop","year":"2010","journal-title":"Biogerontology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","article-title":"Understanding the odd science of aging","volume":"120","author":"TB Kirkwood","year":"2005","journal-title":"Cell"},{"key":"ref3","unstructured":"Busse PJ, Mathur SK (2010) Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol 126: 690\u2013699; quiz 700\u2013691."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"C Franceschi","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0047-6374(03)00025-3","article-title":"Plasma cytokine profiles in elderly humans","volume":"124","author":"RJ Forsey","year":"2003","journal-title":"Mech Ageing Dev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000213568","article-title":"Age-related differences in cytokine secretion","volume":"40","author":"JA Riancho","year":"1994","journal-title":"Gerontology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"M924","DOI":"10.1093\/gerona\/59.9.M924","article-title":"Cytokine-related aging process","volume":"59","author":"JE Morley","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/MI.2005.245","article-title":"Age-related modifications in circulating IL-15 levels in humans","volume":"2005","author":"S Gangemi","year":"2005","journal-title":"Mediators Inflamm"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/cimm.1998.1244","article-title":"CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age","volume":"183","author":"J Chipeta","year":"1998","journal-title":"Cell Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cellimm.2010.10.007","article-title":"Potentiation of Th17 cytokines in aging process contributes to the development of colitis","volume":"266","author":"X Ouyang","year":"2011","journal-title":"Cell Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/593701","article-title":"Depression of antigen-specific interleukin-5 and interferon-gamma responses in human lymphatic filariasis as a function of clinical status and age","volume":"175","author":"E Sartono","year":"1997","journal-title":"J Infect Dis"},{"key":"ref12","first-page":"537","article-title":"Aging, immunity, and cancer","volume":"11","author":"T Fulop","year":"2011","journal-title":"Discov Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"AM De Marzo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1158\/0008-5472.CAN-08-0449","article-title":"Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis","volume":"68","author":"Z Li","year":"2008","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/bies.201100104","article-title":"Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people","volume":"34","author":"M Bonafe","year":"2012","journal-title":"Bioessays"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"L De Monte","year":"2011","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1078-0432.CCR-08-1980","article-title":"Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma","volume":"15","author":"WK Nevala","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"SK Kumar","year":"2008","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"A Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"RA Kyle","year":"2009","journal-title":"Leukemia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0889-8588(05)70435-4","article-title":"Pathogenesis and management of bone lesions in multiple myeloma","volume":"11","author":"R Bataille","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12032-009-9403-9","article-title":"A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival","volume":"28","author":"M Kowalska","year":"2011","journal-title":"Med Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000203602","article-title":"Overproduction of IL-7, IL-10 and TGF-beta 1 in multiple myeloma","volume":"98","author":"H Kroning","year":"1997","journal-title":"Acta Haematol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2249.2001.01582.x","article-title":"Deregulated cytokine network and defective Th1 immune response in multiple myeloma","volume":"125","author":"MA Frassanito","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0889-8588(18)30344-7","article-title":"Cytokine network in human multiple myeloma","volume":"6","author":"B Klein","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V95.2.610","article-title":"Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma","volume":"95","author":"I Tinhofer","year":"2000","journal-title":"Blood"},{"key":"ref27","first-page":"28","article-title":"An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma","volume":"13","author":"ZY Lu","year":"1995","journal-title":"Stem Cells"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"M Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"DH Chang","year":"2005","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2008-02-142430","article-title":"A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma","volume":"112","author":"J Kirshner","year":"2008","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Smyth GK (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor: 397\u2013420.","DOI":"10.1007\/0-387-29362-0_23"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/rheumatology\/ker448","article-title":"IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Ralpha","volume":"51","author":"A Bikker","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4161\/cc.8.13.8985","article-title":"Chronic inflammation, the tumor microenvironment and carcinogenesis","volume":"8","author":"TA Gonda","year":"2009","journal-title":"Cell Cycle"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","article-title":"Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production","volume":"167","author":"SM Liva","year":"2001","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"CJ Malkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"SI Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/intimm\/8.6.855","article-title":"Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12","volume":"8","author":"WG Yu","year":"1996","journal-title":"Int Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02785841","article-title":"Interleukin-10: a cytokine used by tumors to escape immunosurveillance","volume":"16","author":"F Salazar-Onfray","year":"1999","journal-title":"Med Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1634\/stemcells.21-2-236","article-title":"Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD\/SCID mice","volume":"21","author":"A Nitsche","year":"2003","journal-title":"Stem Cells"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2202-8-88","article-title":"The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro","volume":"8","author":"C Kruger","year":"2007","journal-title":"BMC Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4049\/jimmunol.181.1.383","article-title":"IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression","volume":"181","author":"K Kikuchi","year":"2008","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.bbmt.2011.10.036","article-title":"Autologous stem cell transplantation and multiple myeloma cancer stem cells","volume":"18","author":"W Matsui","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.smim.2012.02.001","article-title":"The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation","volume":"24","author":"SA Corfe","year":"2012","journal-title":"Semin Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"E Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","first-page":"930","article-title":"[Serum Level of IL-17 in Patients with Multiple Myeloma and Its Clinical Significance]","volume":"20","author":"XL Zhang","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:49:10Z","timestamp":1595594950000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058504"}},"subtitle":[],"editor":[{"given":"Fabrizio","family":"Mattei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058504","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]}}}